Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR201512001375334Not yet recruiting
Open-label trial of propofol and sevoflurane in hepatitis C virus infection (4 arms), sponsored by Science, Technology & Innovation Funding Authority. Primary endpoint: Effect of study drugs on microRNA. Planned start Dec 2015; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR201512001375334.